Ausgabe 2/2022
Inhalt (24 Artikel)
Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review
Aaron S. Farberg, Alison L. Fitzgerald, Sherrif F. Ibrahim, Stan N. Tolkachjov, Teo Soleymani, Leah M. Douglas, Sarah J. Kurley, Sarah T. Arron
Dapsone in Hidradenitis Suppurativa: A Systematic Review
Aswatha Rabindranathnambi, Balasubramanian Jeevankumar
Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review
Marion Kauth, Olga V. Trusova
Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond
Kazumitsu Sugiura
Photoprotection in Outdoor Sports: A Review of the Literature and Recommendations to Reduce Risk Among Athletes
Yolanda Gilaberte, Carles Trullàs, Corinne Granger, Magdalena de Troya-Martín
Exposome and Skin: Part 1. Bibliometric Analysis and Review of the Impact of Exposome Approaches on Dermatology
Manuel Molina-García, Corinne Granger, Carles Trullàs, Susana Puig
Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen’s Disease and Squamous Cell Carcinoma: A Proposal
Manuel Molina-García, Josep Malvehy, Corinne Granger, Aurora Garre, Carles Trullàs, Susana Puig
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line
Bruce Strober, Joyce Leman, Maja Mockenhaupt, Juliana Nakano de Melo, Ahmed Nassar, Vimal H. Prajapati, Paolo Romanelli, Julien Seneschal, Athanasios Tsianakas, Lee Yoong Wei, Masahito Yasuda, Ning Yu, Ana C. Hernandez Daly, Yukari Okubo
Assessment of Life Quality, Stress and Physical Activity Among Patients with Psoriasis
Julia Nowowiejska, Anna Baran, Paulina Grabowska, Marta Lewoc, Tomasz W. Kaminski, Iwona Flisiak
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials
Mark G. Lebwohl, Ahmed M. Soliman, Hongbo Yang, Jessie Wang, Kaitlin Hagan, Byron Padilla, Andreas Pinter
Development of a Predictive Model for Screening Patients with Psoriasis at Increased Risk of Psoriatic Arthritis
Yiyi Wang, Lingyan Zhang, Min Yang, Yanze Cao, Mingxin Zheng, Yuanxia Gu, Hongxiang Hu, Hui Chen, Min Zhang, Jingyi Li, Li Qiu, Wei Li
Methoxy-Monobenzoylmethane Protects Skin from UV-Induced Damages in a Randomized, Placebo Controlled, Double-Blinded Human In Vivo Study and Prevents Signs of Inflammation While Improving the Skin Barrier
Michael Termer, Anita Jaeger, Christophe Carola, Andrew Salazar, Cornelia M. Keck, Harald Kolmar, Joerg von Hagen
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
Masayuki Tanaka, Yasushi Ozeki, Fujio Matsuyama, Tatsunori Murata, Shinichi Imafuku, Taichi Nakamura
Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
Eggert Stockfleth, Nathalie Bégeault, Alain Delarue
Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis
Akimichi Morita, Yukari Okubo, Yoji Morisaki, Hitoe Torisu-Itakura, Yoshinori Umezawa
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial
Diamant Thaçi, Bruce Strober, Kenneth B. Gordon, Peter Foley, Melinda Gooderham, Akimichi Morita, Kim A. Papp, Lluís Puig, M. Alan Menter, Matthew J. Colombo, Yedid Elbez, Renata M. Kisa, June Ye, Andrew A. Napoli, Lan Wei, Subhashis Banerjee, Joseph F. Merola, Alice B. Gottlieb
Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study
Peter Foley, Tsen-Fang Tsai, Karl Rodins, Issam Ribhi Hamadah, Alfred Ammoury, Hussein Abdel Dayem, Mahmoud Abdallah, Susanne Crowe, Silvia Haas, Effie Pournara, Piotr Jagiello, Yu-Huei Huang
The Impact of Stress-Coping Strategies and the Severity of Psoriasis on Self-Esteem, Illness Acceptance and Life Satisfaction
Beata Kowalewska, Elżbieta Krajewska-Kułak, Marek Sobolewski
Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases
Gustaf Ortsäter, Anna De Geer, Kirk Geale, Alexander Rieem Dun, Ingrid Lindberg, Jacob P. Thyssen, Laura von Kobyletzki, Natalia Ballardini, Dan Henrohn, Petra Neregård, Amy Cha, Joseph C. Cappelleri, Maureen P. Neary
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study
Jeffrey J. Crowley, Richard G. Langley, Kenneth B. Gordon, Andreas Pinter, Laura K. Ferris, Simone Rubant, Huzefa Photowala, Zhenyi Xue, Tianshuang Wu, Tianyu Zhan, Stefan Beeck, Megha Shah, Richard B. Warren
Facial Acne: A Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement
Fabio Rinaldi, Laura Marotta, Antonio Mascolo, Angela Amoruso, Marco Pane, Giammaria Giuliani, Daniela Pinto
Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series
Jeremiah H. Au, Perry B. Hooper, Alison L. Fitzgerald, Ally-Khan Somani
Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up
Magdalena Misiak-Galazka, Joanna Czuwara, Adam Galazka, Anna Czaplicka, Lidia Rudnicka
Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab
Spyridon Gkalpakiotis, Marketa Fridman, Simona Tivadar